What You Should Know:
– Rimidi, a clinical management platform today announced that Desert Oasis Healthcare (DOHC), a regional medical group has implemented Rimidi’s new Respiratory Module.
– Designed to give providers a more complete view of the patient in order to guide treatment decisions for those with respiratory diseases such as chronic obstructive pulmonary disease (COPD) or asthma, the Respiratory Module is enhanced by a collaboration with Teva Pharmaceuticals.
– Data from Teva’s Digihaler family of digital inhalers is brought into clinical workflows via the Rimidi platform, allowing for efficient management of COPD and asthma within the clinician’s existing electronic health record.
